DUTREBIS vs MYSOLINE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. DUTREBIS and MYSOLINE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DUTREBIS	MYSOLINE
Rating	72/100	74/100
Pharmacy pays	$0.43 /mL	~$2.89 /30
Type	RX	RX
Active ingredient	LAMIVUDINE AND RALTEGRAVIR POTASSIUM	PRIMIDONE
Manufacturer	Merck Sharp Dohme	Valeant Pharm Intl
Dosage forms	Tablet	Tablet
Drug class	—	Anti-Epileptic Agent
Boxed warning	None	None
Treats	—	Partial Epilepsies, Tonic-Clonic Epilepsy, Tremor

dutrebis mysoline

Rating

72/100

74/100

Pharmacy pays

$0.43 /mL

~$2.89 /30

Type

Active ingredient

LAMIVUDINE AND RALTEGRAVIR POTASSIUM

PRIMIDONE

Manufacturer

Merck Sharp Dohme

Valeant Pharm Intl

Dosage forms

Tablet

Drug class

—

Anti-Epileptic Agent

Boxed warning

None

Treats

—

Partial Epilepsies, Tonic-Clonic Epilepsy, Tremor

Frequently asked questions

Which is better-rated, Dutrebis or Mysoline?

By our independent rating, Mysoline scores higher — 3.7 vs 3.6 out of 5 for Dutrebis. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Dutrebis and Mysoline?

Dutrebis contains Lamivudine and Raltegravir Potassium, while Mysoline contains Primidone — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.